Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 19341-19350 Newer>

The Motley Fool December 21, 2006 Rick Aristotle Munarriz	Herman Miller Sitting Pretty The office furniture giant waxes optimistic in its latest quarter. Investors, take note.
The Motley Fool December 21, 2006 David Meier	A Cushy Quarter for Herman Miller: Fool by Numbers The furniture designer and manufacturer released its earnings for the second quarter 2007: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool December 21, 2006 Jean Graham	Halliburton and KBR Call It Quits Breaking up isn't hard to do. Shareholders who would prefer to hold a pure play in the energy services sector may rejoice in the new, leaner Halliburton, currently selling at a discount to its competitors.
The Motley Fool December 21, 2006 Ryan Fuhrmann	Dueling Fools: Merck Bear Rebuttal Yes, Merck is a good company, but investors can still do better.
The Motley Fool December 21, 2006 Ryan Fuhrmann	Dueling Fools: Merck Bear Investors, because of its recent run-up, the risk/reward tradeoff is not very compelling. There are safer, more lucrative ways to invest in the space.
The Motley Fool December 21, 2006 Rich Smith	No Looking Back for Palm Yes, there's those darn second-quarter numbers. There's no denying the results were miserable -- and yet, the stock didn't sink on the news. Why?
The Motley Fool December 21, 2006 Brian Lawler	Dueling Fools: Merck Bull Rebuttal Plenty of cash. Big pipeline. Not to worry. The future can't be predicted, but Merck's history shows its ability to weather even the toughest pharmaceutical-development environments.
The Motley Fool December 21, 2006 Matthew Crews	General Mills Grinds Higher The packaged-food conglomerate increases its outlook for the second half of the fiscal year. Investors, take note.
The Motley Fool December 21, 2006 Brian Lawler	Dueling Fools: Merck Bull What you are getting with Merck is one of the best-managed pharmas out there that will be experiencing solid double-digit earnings growth in the not-too-distant future with a smart dividend payout.
The Motley Fool December 21, 2006 Alyce Lomax	Chico's Bids Goodbye to the Gralnicks The retailer's founders retire; should investors be concerned?
<Older 19341-19350 Newer> Return to current articles.